New Research Trial Aims to Develop Disease-Modifying Drug for Osteoarthritis

Strategic Insights -

A groundbreaking research study at Frimley Health is underway to develop a novel disease-modifying drug for osteoarthritis. The RAMBOH-1 research trial aims to provide new hope for individuals suffering from this debilitating condition, which affects over 40% of people during their lifetime. Hand osteoarthritis, particularly common in women around menopause, causes pain, stiffness, and swelling in the thumb joint, hindering daily activities such as writing and opening jars. Researchers at Oxford University have identified a potential drug, talarozole, which may reduce inflammation in arthritic cartilage and prevent or even reverse arthritis. The study will investigate the effects of talarozole on joint tissues in patients undergoing surgery for hand osteoarthritis.

Key Takeaways:

  • The RAMBOH-1 research trial at Frimley Health aims to develop a new disease-modifying drug for osteoarthritis, preventing chronic pain and enabling people to live well with the condition.
  • Osteoarthritis affects over 40% of people during their lifetime, with hand osteoarthritis being a common form, particularly in women around menopause.
  • The base of the thumb joint is often affected, leading to pain, stiffness, and swelling, and causing difficulty with activities such as writing and opening jars.
  • Researchers at Oxford University have identified a potential drug, talarozole, which may reduce inflammation in arthritic cartilage and prevent or even reverse arthritis.
  • The study will investigate the effects of talarozole on joint tissues in patients undergoing surgery for hand osteoarthritis.
  • Current treatment options for hand OA include pain relief such as anti-inflammatory gels, steroid injections, or surgery.
  • The research trial will provide valuable information to help plan a larger study in the future, potentially paving the way for new treatments for osteoarthritis.

Statistics:

  • Over 40% of people will develop osteoarthritis during their lifetime.
  • Hand osteoarthritis affects women, especially around menopause, causing pain, stiffness, and swelling in the thumb joint.
  • The current treatment options for hand osteoarthritis include pain relief such as anti-inflammatory gels, steroid injections, or surgery.

Sources:

  • Frimley Health NHS Foundation Trust